The startup operates a digital diagnostics platform that utilizes novel biosensors and hardware to capture both audible and inaudible sounds from human vital organs. This technology enables healthcare providers to autonomously screen for chronic respiratory diseases, including COPD and pulmonary hypertension, by interpreting traditional physiological signals through transparent AI and machine learning algorithms.
Funding
$2.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional methods for screening and monitoring chronic respiratory diseases often rely on subjective assessments and may not detect subtle changes in physiological signals. Existing diagnostic tools can be cumbersome, expensive, and require specialized training, limiting accessibility and hindering early detection. This can lead to delayed diagnoses and suboptimal management of conditions like COPD and pulmonary hypertension.
Solution
Level42 AI offers a digital diagnostics platform that employs advanced biosensors and hardware to capture both audible and inaudible sounds from vital organs. Their technology utilizes sensor fusion and generative AI to interpret complex vibroacoustic biosignatures, enabling healthcare providers to autonomously screen for chronic respiratory diseases. The platform's algorithms analyze traditionally overlooked data, identifying subtle indicators of disease that may be missed by conventional instruments. By mapping the human vibrome, Level42 AI aims to provide earlier detection, more accurate diagnoses, and convenient monitoring for patients, ultimately improving outcomes and bridging the gap between hospital and home care. The system offers point-of-care, point-of-habitat, and point-of-person solutions for continuous health monitoring.
Target Audience
The primary target audience includes healthcare providers in telemedicine, urgent care, and senior care settings, as well as individuals seeking proactive and preventive WELLcare solutions for continuous health monitoring.
Features
- Broad frequency bandwidth infrasonic-to-ultrasonic vibroacoustic biosensors for comprehensive data capture
- Generative AI algorithms for signal processing and accurate interpretation of vibroacoustic biosignatures
- Non-contact, passive monitoring capabilities for continuous data collection
- Point-of-care solutions for telemedicine platforms, urgent care, and senior care
- Point-of-habitat solutions for integration into furniture for continuous health monitoring
- Point-of-person solutions including wearable devices for self-directed care
- Software-defined sensor fusion for capturing silent and invisible signals